Literature DB >> 30231320

Cancer Care for Refugees and Displaced Populations: Middle East Conflicts and Global Natural Disasters.

Nagi S El Saghir1, Enrique Soto Pérez de Celis1, Johny E Fares1, Richard Sullivan1.   

Abstract

Conflicts and natural disasters can cause major disruptions to people's lives. Media and news agencies usually focus on immediate consequences of these events, including loss of life and injuries, environmental and property destruction, and relief efforts. In this article, we will examine the effects of conflicts (focusing on in the Middle East) and global natural disasters on patients already diagnosed with cancer and on those who are diagnosed with cancer during and in the immediate aftermath of these events. We will review the limited literature, provide situational analysis, and discuss medical relief efforts, governmental readiness, and the role of United Nations agencies and international nongovernmental organizations. We will also discuss treatment of patients with cancer in the context of prolonged displacements and limited resources.

Entities:  

Mesh:

Year:  2018        PMID: 30231320     DOI: 10.1200/EDBK_201365

Source DB:  PubMed          Journal:  Am Soc Clin Oncol Educ Book        ISSN: 1548-8748


  16 in total

1.  Access to Radiation Therapy by Syrian Refugees Displaced to Turkey.

Authors:  Nergiz Dagoglu; Sule Karaman; Banu Atalar; Robert C Miller; Ethem N Oral
Journal:  Adv Radiat Oncol       Date:  2022-07-15

Review 2.  Interruption of cancer screening services due to COVID-19 pandemic: lessons from previous disasters.

Authors:  Douglas M Puricelli Perin; Tess Christensen; Andrea Burón; Jennifer S Haas; Aruna Kamineni; Nora Pashayan; Linda Rabeneck; Robert Smith; Miriam Elfström; Mireille J M Broeders
Journal:  Prev Med Rep       Date:  2021-05-17

3.  Cancer Care After the 2017 Central Mexico Earthquake.

Authors:  Jacqueline Alcalde-Castro; Thierry Hernández-Gilsoul; Ismael Domínguez-Rosado; Yanin Chavarri-Guerra; Enrique Soto Perez-de-Celis
Journal:  J Glob Oncol       Date:  2018-07

4.  Using Intervention Mapping to Develop Health Education and Health Policy Components to Increase Breast Cancer Screening and Chemotherapy Adherence Among Syrian and Iraqi Refugee Women in Beirut, Lebanon.

Authors:  Lea Sacca; Christine Markham; Johny Fares
Journal:  Front Public Health       Date:  2020-04-15

5.  Cervical cancer screening rates before and after the Great East Japan Earthquake in the Miyagi Prefecture, Japan.

Authors:  Yasuhiro Miki; Toru Tase; Hideki Tokunaga; Nobuo Yaegashi; Kiyoshi Ito
Journal:  PLoS One       Date:  2020-03-11       Impact factor: 3.240

6.  Knowledge of cervical cancer risk factors and symptoms among women in a refugee settlement: a cross-sectional study in northern Uganda.

Authors:  Winnie Adoch; Christopher Orach Garimoi; Suzanne E Scott; Geoffrey Goddie Okeny; Jennifer Moodley; Henry Komakech; Fiona M Walter; Amos Deogratius Mwaka
Journal:  Confl Health       Date:  2020-12-03       Impact factor: 2.723

7.  Strengthening capacity for cancer research in conflict settings: key informant insights from the Middle East.

Authors:  Zahi Abdul-Sater; Marilyne Menassa; Nassim El Achi; Rima A Abdul-Khalek; Ghassan Abu-Sittah; Deborah Mukherji
Journal:  Ecancermedicalscience       Date:  2020-12-10

8.  Burden of Cancer Among Syrian Refugees in Jordan.

Authors:  Asem Mansour; Amal Al-Omari; Iyad Sultan
Journal:  J Glob Oncol       Date:  2018-10

9.  Late presentation and suboptimal treatment of breast cancer among Syrian refugees: a retrospective study.

Authors:  Hikmat Abdel-Razeq; Faris Tamimi; Nayef Abdel-Razeq; Maryam El-Atrash; Baha' Sharaf; Rawan Mustafa; Razan Mansour; Rayan Bater
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

10.  The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis.

Authors:  Felippe O Marcondes; David Cheng; Erica T Warner; Sophia C Kamran; Jennifer S Haas
Journal:  Prev Med       Date:  2021-06-30       Impact factor: 4.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.